Role of sigma-1 receptors in neurodegenerative diseases.

Nguyen L, Lucke-Wold BP, Mookerjee SA, Cavendish JZ, Robson MJ, Scandinaro AL, Matsumoto RR
J Pharmacol Sci. 2015 127 (1): 17-29

PMID: 25704014 · DOI:10.1016/j.jphs.2014.12.005

Neurodegenerative diseases with distinct genetic etiologies and pathological phenotypes appear to share common mechanisms of neuronal cellular dysfunction, including excitotoxicity, calcium dysregulation, oxidative damage, ER stress and mitochondrial dysfunction. Glial cells, including microglia and astrocytes, play an increasingly recognized role in both the promotion and prevention of neurodegeneration. Sigma receptors, particularly the sigma-1 receptor subtype, which are expressed in both neurons and glia of multiple regions within the central nervous system, are a unique class of intracellular proteins that can modulate many biological mechanisms associated with neurodegeneration. These receptors therefore represent compelling putative targets for pharmacologically treating neurodegenerative disorders. In this review, we provide an overview of the biological mechanisms frequently associated with neurodegeneration, and discuss how sigma-1 receptors may alter these mechanisms to preserve or restore neuronal function. In addition, we speculate on their therapeutic potential in the treatment of various neurodegenerative disorders.

Copyright © 2015. Production and hosting by Elsevier B.V.

MeSH Terms (8)

Animals Humans Models, Biological Molecular Targeted Therapy Nerve Degeneration Neurodegenerative Diseases Neuroprotective Agents Receptors, sigma

Connections (1)

This publication is referenced by other Labnodes entities: